Market Access & Pricing
Price with intent. Access without delay.
Access is where launch revenue is won or lost — and where Asian markets punish imprecision. Payer structures, pricing corridors, and HTA expectations differ sharply by country. A dossier built for one market rarely survives the next without rework.
We set price with intent — based on value, competitive set, and cross-market spillover — and build the access plan country by country, in the sequence that protects the global corridor.
Outcomes
• Defensible launch price across key Asian markets
• Sequenced access plan that protects the global corridor
• HTA- and payer-ready value narrative
• Access timelines shortened where corridors allow
The problem
Where access stalls
Access delays usually come from evidence, sequencing, or payer logic being treated too late. These are strategic decisions, not submission details.
Value narrative built for the wrong audience
A dossier written for regulators is not a dossier payers will pay for. When the evidence story does not speak the payer's language, negotiations restart from zero — and the launch window moves.
Price corridor eroded by sequencing
Launch order across Asia is not administrative — it is a pricing decision. The wrong sequence locks in a reference price that caps every subsequent market for the product's lifetime.
Fragmented payer and HTA expectations
Each country reads evidence differently. Japan, Korea, Taiwan, Australia and Thailand all want something specific — and sending the same pack to each is the fastest way to stall access in all of them.
Detailed service breakdown
Want the detailed Market Access & Pricing breakdown?
Leave your email and we will send the fuller service detail, including access sequencing, pricing corridor design, value narrative, and payer engagement support.
Request Details